SEC Tracker
Get the app

NRX Pharmaceuticals NRXP

NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Press release
  • Signs a material agreement (1.01)
  • Sells unregistered shares (3.02)
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when NRX Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. iBio IBIO public float $58M, Dec 31, 2025
  2. Sutro Biopharma STRO public float $60M, Jun 30, 2025
  3. PDS Biotechnology PDSB public float $60M, Jun 30, 2025
  4. Avalo Therapeutics AVTX public float $54M, Jun 30, 2025
  5. Medicinova MNOV public float $62M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.